Suchergebnisse - "Boussageon, Maxime"

PubPharm (17)

1

Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Dehem, A. | Mazieres, J. | Chour, A. | +16

2

Occupational asbestos exposure and survival among lung cancer patients

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Noelle, H. | Pérol, O. | Pérol, M. | +14

3

Survival of bronchopulmonary cancers according to radon exposure

enthalten in: Frontiers in public health | 2023

von Dessemon, J. | Perol, O. | Chauvel, C. | +17

4

Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC

enthalten in: Frontiers in radiology | 2023

von Bouhamama, A. | Leporq, B. | Faraz, K. | +8

5

Correction to : First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2023

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

ErratumFor: BioDrugs. 2022 Mar;36(2):137-151. - PMID 35147894

6

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

7

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

8

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

9

Immunologically active phenotype by gene expression profiling is associated with clinical benefit from PD-1/PD-L1 inhibitors in real-world head and neck and lung cancer patients

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Foy, J. | Karabajakian, A. | Ortiz-Cuaran, S. | +22

10

Datasets for gene expression profiles of head and neck squamous cell carcinoma and lung cancer treated or not by PD1/PD-L1 inhibitors

enthalten in: Data in brief | 2022

von Foy, J. | Karabajakian, A. | Ortiz-Cuaran, S. | +22